Related references
Note: Only part of the references are listed.Factors associated with fear of cancer recurrence in breast and colorectal cancer survivors: A cross-sectional study of cancer survivors
Sharon H. Nahm et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Use of the Delphi method to develop a guideline-based geriatric oncology gap assessment
Elana Plotkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Screening for fear of cancer recurrence: Instrument validation and current status in early stage lung cancer patients
Yun-Hsiang Lee et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
S. S. Ramalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
Run-Cong Nie et al.
BMC CANCER (2020)
Real-world disease burden and outcomes of brain metastases in EGFR mutation-positive non-small-cell lung cancer
Eric Nadler et al.
FUTURE ONCOLOGY (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Delphi Technique in Health Sciences: A Map
Marlen Niederberger et al.
FRONTIERS IN PUBLIC HEALTH (2020)
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
Song-Tao Xu et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
Min Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Clinical Oncology Society of Australia position statement on cancer survivorship care
Janette L. Vardy et al.
AUSTRALIAN JOURNAL OF GENERAL PRACTICE (2019)
Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings
Mark S. Walker et al.
CLINICAL LUNG CANCER (2018)
Adjuvant treatment for EGFR-mutated non-small cell lung cancer: do we have a major breakthrough?
Giandomenico Roviello et al.
JOURNAL OF THORACIC DISEASE (2018)
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study
Christos Chouaid et al.
LUNG CANCER (2018)
Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?
Griet Deslypere et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. E. Postmus et al.
ANNALS OF ONCOLOGY (2017)
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer
Solange Peters et al.
CANCER TREATMENT REVIEWS (2016)
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
Karen Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach
F. Rotolo et al.
ANNALS OF ONCOLOGY (2014)
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
Koji Oba et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
Audrey Mauguen et al.
LANCET ONCOLOGY (2013)
Using the Delphi Technique to Improve Clinical Outcomes Through the Development of Quality Indicators in Renal Cell Carcinoma
Lori Wood et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
Review: Adjuvant therapy for resected non-small cell lung cancer
Antoinette J. Wozniak et al.
Therapeutic Advances in Medical Oncology (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Individual- and trial-level surrogacy in colorectal cancer
Marc Buyse et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
K Hotta et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The Delphi technique: myths and realities
C Powell
JOURNAL OF ADVANCED NURSING (2003)
Share Paper
